Managed Access Programs for BYL719, Alpelisib

NCT04085653 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

PIK3CA-Related Overgrowth Spectrum (PROS)
Breast Cancer

Interventions

DRUG: alpelisib

Sponsor

Novartis Pharmaceuticals